Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Rheumatoid Arthritis

Free Subscription 06.02.2023 1 Ann Rheum Dis 2 Clin Exp Rheumatol 1 Clin Rheumatol 1 Intern Med 4 J Rheumatol 1 PLoS One 1 Rheumatol Int

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Rheum Dis

1. DOUGADOS M, Charles-Schoeman C, Szekanecz Z, Giles JT, et al
   Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme.
   Ann Rheum Dis. 2023 Jan 31:ard-2022-223406. doi: 10.1136/ard-2022-223406.
   PubMed        
   
   

   
   Clin Exp Rheumatol

2. ALMEIDA-SANTIAGO C, Quevedo-Abeledo JC, Hernandez-Hernandez V, de Vera-Gonzalez A, et al
   Circulating interleukin-6 and cardiovascular disease risk in patients with rheumatoid arthritis with low disease activity due to active therapy.
   Clin Exp Rheumatol. 2023 Jan 31. doi: 10.55563.
   PubMed         Abstract available
   
   
3. KOHNO H, Sugimoto T, Yoshida Y, Mokuda S, et al
   Association between increased serum IL-23 levels and ACPA positivity in patients with rheumatoid arthritis.
   Clin Exp Rheumatol. 2023 Jan 31. doi: 10.55563.
   PubMed        
   
   

   
   Clin Rheumatol

4. KAKEHASI AM, Radominski SC, Baravalle MD, Palazuelos FCI, et al
   Safety of upadacitinib in Latin American patients with rheumatoid arthritis: an integrated safety analysis of the SELECT phase 3 clinical program.
   Clin Rheumatol. 2023 Jan 30:1-10. doi: 10.1007/s10067-023-06513.
   PubMed         Abstract available
   
   

   
   Intern Med

5. HASEGAWA E, Ito S, Kurosawa Y, Kobayashi D, et al
   The Efficacy of Biological Disease-modifying Antirheumatic Drugs on Sarcopenia in Patients with Rheumatoid Arthritis.
   Intern Med. 2023;62:373-379.
   PubMed         Abstract available
   
   

   
   J Rheumatol

6. DAVTYAN A, Lee JJY, Eder L, Hawker GA, et al
   The Effects of Continuity of Rheumatology Care on Emergency Department Utilization and Hospitalizations for Individuals With Early Rheumatoid Arthritis: A Population-Based Study.
   J Rheumatol. 2023 Feb 1:jrheum.220996. doi: 10.3899/jrheum.220996.
   PubMed         Abstract available
   
   
7. KAUR J, Cairns E, Barra L
   Restoring Balance: Immune Tolerance in Rheumatoid Arthritis.
   J Rheumatol. 2023 Feb 1:jrheum.220881. doi: 10.3899/jrheum.220881.
   PubMed         Abstract available
   
   
8. SINGER D, Thompson-Leduc P, Poston S, Gupta D, et al
   Incidence of Herpes Zoster in Patients with Rheumatoid Arthritis in the United States: A Retrospective Cohort Study.
   J Rheumatol. 2023 Feb 1:jrheum.220986. doi: 10.3899/jrheum.220986.
   PubMed         Abstract available
   
   
9. BARBER CEH, Lacaille D, Croxford R, Barnabe C, et al
   Investigating Associations Between Access to Rheumatology Care, Treatment, Continuous Care, and Healthcare Utilization and Costs Among Older Individuals With Rheumatoid Arthritis.
   J Rheumatol. 2023 Jan 15:jrheum.220729. doi: 10.3899/jrheum.220729.
   PubMed         Abstract available
   
   

   
   PLoS One

10. CONIGLIARO P, D'Antonio A, D'Erme L, Lavinia Fonti G, et al
    Failure and multiple failure for disease modifying antirheumatic drugs in rheumatoid arthritis: Real-life evidence from a tertiary referral center in Italy.
    PLoS One. 2023;18:e0281213.
    PubMed         Abstract available
    
    

    
    Rheumatol Int

11. WIEGEL J, Seppen BF, Nurmohamed MT, Ter Wee MM, et al
    Predictors for response to electronic patient-reported outcomes in routine care in patients with rheumatoid arthritis: a retrospective cohort study.
    Rheumatol Int. 2023 Jan 30:1-7. doi: 10.1007/s00296-023-05278.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: